Last reviewed · How we verify

Phenoxymethylpenicillin — Competitive Intelligence Brief

Phenoxymethylpenicillin (Phenoxymethylpenicillin) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Immunology.

marketed Bacterial penicillin-binding protein, Penicillin-binding protein 1A Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Phenoxymethylpenicillin (Phenoxymethylpenicillin) — Katarina Hedin.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Phenoxymethylpenicillin TARGET Phenoxymethylpenicillin Katarina Hedin marketed Bacterial penicillin-binding protein, Penicillin-binding protein 1A
Bl-S786R CEFORANIDE marketed ceforanide Bacterial penicillin-binding protein, Penicillin-binding protein 1A 1984-01-01
Cefobid CEFOPERAZONE marketed Cephalosporin Antibacterial Bacterial penicillin-binding protein, Penicillin-binding protein 1A 1982-01-01
Cefazoline Cefazoline Nantes University Hospital marketed Bacterial penicillin-binding protein, Penicillin-binding protein 1A

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Phenoxymethylpenicillin — Competitive Intelligence Brief. https://druglandscape.com/ci/phenoxymethylpenicillin. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing